The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation

Anne Abot, Coralie Fontaine, Mélissa Buscato, Romain Solinhac, Gilles Flouriot, Aurélie Fabre, Anne Drougard, Shyamala Rajan, Muriel Laine, Alain Milon, Isabelle Muller, Daniel Henrion, Marine Adlanmerini, Marie Cécile Valéra, Anne Gompel, Céline Gerard, Christel Péqueux, Mélanie Mestdagt, Isabelle Raymond-Letron, Claude Knauf & 9 others François Ferriere, Philippe Valet, Pierre Gourdy, Benita S Katzenellenbogen, John A. Katzenellenbogen, Françoise Lenfant, Geoffrey L. Greene, Jean Michel Foidart, Jean François Arnal

Research output: Contribution to journalArticle

Abstract

Estetrol (E4) is a natural estrogen with a long half-life produced only by the human fetal liver during pregnancy. The crystal structures of the estrogen receptor α (ERα) ligand-binding domain bound to 17β-estradiol (E2) and E4 are very similar, as well as their capacity to activate the two activation functions AF-1 and AF-2 and to recruit the coactivator SRC3. In vivo administration of high doses of E4 stimulated uterine gene expression, epithelial proliferation, and prevented atheroma, three recognized nuclear ERα actions. However, E4 failed to promote endothelial NO synthase activation and acceleration of endothelial healing, two processes clearly dependent on membrane-initiated steroid signaling (MISS). Furthermore, E4 antagonized E2 MISS-dependent effects in endothelium but also in MCF-7 breast cancer cell line. This profile of ERα activation by E4, uncoupling nuclear and membrane activation, characterizes E4 as a selective ER modulator which could have medical applications that should now be considered further.

Original languageEnglish (US)
Pages (from-to)1328-1346
Number of pages19
JournalEMBO Molecular Medicine
Volume6
Issue number10
DOIs
StatePublished - Oct 1 2014

Fingerprint

Estetrol
Nuclear Envelope
Estrogen Receptors
Blood Vessels
Furylfuramide
Steroids
Selective Estrogen Receptor Modulators
Membranes
Atherosclerotic Plaques
Nitric Oxide Synthase
Endothelium
Half-Life
Estradiol
Estrogens
Breast Neoplasms
Ligands
Gene Expression
Cell Line
Pregnancy
Liver

Keywords

  • Endothelium
  • Estetrol
  • Estrogen receptor
  • Uterus

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation. / Abot, Anne; Fontaine, Coralie; Buscato, Mélissa; Solinhac, Romain; Flouriot, Gilles; Fabre, Aurélie; Drougard, Anne; Rajan, Shyamala; Laine, Muriel; Milon, Alain; Muller, Isabelle; Henrion, Daniel; Adlanmerini, Marine; Valéra, Marie Cécile; Gompel, Anne; Gerard, Céline; Péqueux, Christel; Mestdagt, Mélanie; Raymond-Letron, Isabelle; Knauf, Claude; Ferriere, François; Valet, Philippe; Gourdy, Pierre; Katzenellenbogen, Benita S; Katzenellenbogen, John A.; Lenfant, Françoise; Greene, Geoffrey L.; Foidart, Jean Michel; Arnal, Jean François.

In: EMBO Molecular Medicine, Vol. 6, No. 10, 01.10.2014, p. 1328-1346.

Research output: Contribution to journalArticle

Abot, A, Fontaine, C, Buscato, M, Solinhac, R, Flouriot, G, Fabre, A, Drougard, A, Rajan, S, Laine, M, Milon, A, Muller, I, Henrion, D, Adlanmerini, M, Valéra, MC, Gompel, A, Gerard, C, Péqueux, C, Mestdagt, M, Raymond-Letron, I, Knauf, C, Ferriere, F, Valet, P, Gourdy, P, Katzenellenbogen, BS, Katzenellenbogen, JA, Lenfant, F, Greene, GL, Foidart, JM & Arnal, JF 2014, 'The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation', EMBO Molecular Medicine, vol. 6, no. 10, pp. 1328-1346. https://doi.org/10.15252/emmm.201404112
Abot, Anne ; Fontaine, Coralie ; Buscato, Mélissa ; Solinhac, Romain ; Flouriot, Gilles ; Fabre, Aurélie ; Drougard, Anne ; Rajan, Shyamala ; Laine, Muriel ; Milon, Alain ; Muller, Isabelle ; Henrion, Daniel ; Adlanmerini, Marine ; Valéra, Marie Cécile ; Gompel, Anne ; Gerard, Céline ; Péqueux, Christel ; Mestdagt, Mélanie ; Raymond-Letron, Isabelle ; Knauf, Claude ; Ferriere, François ; Valet, Philippe ; Gourdy, Pierre ; Katzenellenbogen, Benita S ; Katzenellenbogen, John A. ; Lenfant, Françoise ; Greene, Geoffrey L. ; Foidart, Jean Michel ; Arnal, Jean François. / The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation. In: EMBO Molecular Medicine. 2014 ; Vol. 6, No. 10. pp. 1328-1346.
@article{9926a29a2d4e431c8d7cbe65c4e80e1f,
title = "The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation",
abstract = "Estetrol (E4) is a natural estrogen with a long half-life produced only by the human fetal liver during pregnancy. The crystal structures of the estrogen receptor α (ERα) ligand-binding domain bound to 17β-estradiol (E2) and E4 are very similar, as well as their capacity to activate the two activation functions AF-1 and AF-2 and to recruit the coactivator SRC3. In vivo administration of high doses of E4 stimulated uterine gene expression, epithelial proliferation, and prevented atheroma, three recognized nuclear ERα actions. However, E4 failed to promote endothelial NO synthase activation and acceleration of endothelial healing, two processes clearly dependent on membrane-initiated steroid signaling (MISS). Furthermore, E4 antagonized E2 MISS-dependent effects in endothelium but also in MCF-7 breast cancer cell line. This profile of ERα activation by E4, uncoupling nuclear and membrane activation, characterizes E4 as a selective ER modulator which could have medical applications that should now be considered further.",
keywords = "Endothelium, Estetrol, Estrogen receptor, Uterus",
author = "Anne Abot and Coralie Fontaine and M{\'e}lissa Buscato and Romain Solinhac and Gilles Flouriot and Aur{\'e}lie Fabre and Anne Drougard and Shyamala Rajan and Muriel Laine and Alain Milon and Isabelle Muller and Daniel Henrion and Marine Adlanmerini and Val{\'e}ra, {Marie C{\'e}cile} and Anne Gompel and C{\'e}line Gerard and Christel P{\'e}queux and M{\'e}lanie Mestdagt and Isabelle Raymond-Letron and Claude Knauf and Fran{\cc}ois Ferriere and Philippe Valet and Pierre Gourdy and Katzenellenbogen, {Benita S} and Katzenellenbogen, {John A.} and Fran{\cc}oise Lenfant and Greene, {Geoffrey L.} and Foidart, {Jean Michel} and Arnal, {Jean Fran{\cc}ois}",
year = "2014",
month = "10",
day = "1",
doi = "10.15252/emmm.201404112",
language = "English (US)",
volume = "6",
pages = "1328--1346",
journal = "EMBO Molecular Medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation

AU - Abot, Anne

AU - Fontaine, Coralie

AU - Buscato, Mélissa

AU - Solinhac, Romain

AU - Flouriot, Gilles

AU - Fabre, Aurélie

AU - Drougard, Anne

AU - Rajan, Shyamala

AU - Laine, Muriel

AU - Milon, Alain

AU - Muller, Isabelle

AU - Henrion, Daniel

AU - Adlanmerini, Marine

AU - Valéra, Marie Cécile

AU - Gompel, Anne

AU - Gerard, Céline

AU - Péqueux, Christel

AU - Mestdagt, Mélanie

AU - Raymond-Letron, Isabelle

AU - Knauf, Claude

AU - Ferriere, François

AU - Valet, Philippe

AU - Gourdy, Pierre

AU - Katzenellenbogen, Benita S

AU - Katzenellenbogen, John A.

AU - Lenfant, Françoise

AU - Greene, Geoffrey L.

AU - Foidart, Jean Michel

AU - Arnal, Jean François

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Estetrol (E4) is a natural estrogen with a long half-life produced only by the human fetal liver during pregnancy. The crystal structures of the estrogen receptor α (ERα) ligand-binding domain bound to 17β-estradiol (E2) and E4 are very similar, as well as their capacity to activate the two activation functions AF-1 and AF-2 and to recruit the coactivator SRC3. In vivo administration of high doses of E4 stimulated uterine gene expression, epithelial proliferation, and prevented atheroma, three recognized nuclear ERα actions. However, E4 failed to promote endothelial NO synthase activation and acceleration of endothelial healing, two processes clearly dependent on membrane-initiated steroid signaling (MISS). Furthermore, E4 antagonized E2 MISS-dependent effects in endothelium but also in MCF-7 breast cancer cell line. This profile of ERα activation by E4, uncoupling nuclear and membrane activation, characterizes E4 as a selective ER modulator which could have medical applications that should now be considered further.

AB - Estetrol (E4) is a natural estrogen with a long half-life produced only by the human fetal liver during pregnancy. The crystal structures of the estrogen receptor α (ERα) ligand-binding domain bound to 17β-estradiol (E2) and E4 are very similar, as well as their capacity to activate the two activation functions AF-1 and AF-2 and to recruit the coactivator SRC3. In vivo administration of high doses of E4 stimulated uterine gene expression, epithelial proliferation, and prevented atheroma, three recognized nuclear ERα actions. However, E4 failed to promote endothelial NO synthase activation and acceleration of endothelial healing, two processes clearly dependent on membrane-initiated steroid signaling (MISS). Furthermore, E4 antagonized E2 MISS-dependent effects in endothelium but also in MCF-7 breast cancer cell line. This profile of ERα activation by E4, uncoupling nuclear and membrane activation, characterizes E4 as a selective ER modulator which could have medical applications that should now be considered further.

KW - Endothelium

KW - Estetrol

KW - Estrogen receptor

KW - Uterus

UR - http://www.scopus.com/inward/record.url?scp=84908099857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908099857&partnerID=8YFLogxK

U2 - 10.15252/emmm.201404112

DO - 10.15252/emmm.201404112

M3 - Article

VL - 6

SP - 1328

EP - 1346

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

IS - 10

ER -